for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up

Koninklijke Philips NV

PHG.AS

前日終値

40.95EUR

変化

0.80(+1.99%)

出来高

2,570,459

本日のレンジ

40.43

 - 

41.07

52週レンジ

29.05

 - 

44.60

∙ 約15分前の相場を表示しています。

適時開示

Philips Announces First Setup Of Intellispace Critical Care And Anesthesia System In Indonesia

Nov 14 (Reuters) - KONINKLIJKE PHILIPS NV <PHG.AS>::PHILIPS ANNOUNCES FIRST INSTALLATION OF INTELLISPACE CRITICAL CARE AND ANESTHESIA SYSTEM AT KASIH IBU HOSPITAL IN BALI, INDONESIA.

Philips Q3 Adjusted EBITA Up At 583 Million Euros

Oct 28 (Reuters) - KONINKLIJKE PHILIPS NV <PHG.AS>::PHILIPS DELIVERS Q3 SALES OF EUR 4.7 BILLION, WITH 6% COMPARABLE SALES GROWTH, EUR 211 MILLION INCOME FROM CONTINUING OPERATIONS AND AN ADJUSTED EBITA MARGIN OF 12.4%.SALES IN QUARTER AMOUNTED TO EUR 4.7 BILLION, WITH 6% COMPARABLE SALES GROWTH.Q3 COMPARABLE ORDER INTAKE WAS IN LINE WITH Q3 2018.IN Q3, WE DELIVERED MIXED RESULTS FOR GROUP - CEO.Q3 INCOME FROM CONTINUING OPERATIONS AMOUNTED TO EUR 211 MILLION.FOR FULL-YEAR 2019, WE CONTINUE TO EXPECT GROWTH TO BE WITHIN 4-6% RANGE - CEO.Q3 ADJUSTED EBITA EUR 583 MLN VS EUR 568 MLN YEAR AGO.Q3 ADJUSTED EBITA MARGIN WAS 12.4% OF SALES, COMPARED TO 13.2% OF SALES IN Q3 2018.Q3 INCOME FROM OPERATIONS AMOUNTED TO EUR 320 MILLION, COMPARED TO EUR 451 MILLION IN Q3 2018.WE EXPECT ADJUSTED EBITA MARGIN TO IMPROVE AROUND 10 TO 20 BASIS POINTS - CEO.Q3 EPS FROM CONTINUING OPERATIONS (DILUTED) AMOUNTED TO EUR 0.23.FOR 2020, WE EXPECT 4-6% COMPARABLE SALES GROWTH AND AN ADJUSTED EBITA MARGIN IMPROVEMENT OF AROUND 100 BASIS POINTS - CEO.Q3 OPERATING CASH FLOW INCREASED TO EUR 356 MILLION, COMPARED TO EUR 265 MILLION IN Q3 2018.Q3 FREE CASH FLOW INCREASED TO EUR 126 MILLION, COMPARED TO EUR 52 MILLION IN Q3 2018.Q3 COMPARABLE ORDER INTAKE WAS FLAT, ON BACK OF STRONG 11% GROWTH IN Q3 OF 2018, REFLECTING UNEVENNESS OF ORDER INTAKE DYNAMICS AND SOFTNESS IN NORTH AMERICA.

Philips, Klinikum Stuttgart Hospital Sign Innovation Partnership

Oct 18 (Reuters) - Koninklijke Philips NV <PHG.AS>::PHILIPS AND KLINIKUM STUTTGART HOSPITAL SIGN 10-YEAR INNOVATION PARTNERSHIP AGREEMENT.LONG-TERM STRATEGIC PARTNERSHIP FOCUSES ON QUALITY IMPROVEMENT THROUGH DIGITIZATION, THE PROVISION OF INNOVATIVE CONNECTED CARE TECHNOLOGIES AND CLINICAL RESEARCH COLLABORATION.

Philips Sees Q3 Group Adjusted EBITA At Around 583 Million Euros

Oct 10 (Reuters) - KONINKLIJKE PHILIPS NV <PHG.AS>::PHILIPS PROVIDES UPDATE ON ITS FINANCIAL PERFORMANCE IN Q3 2019.GROUP SALES FOR QUARTER ARE EXPECTED TO AMOUNT TO APPROXIMATELY EUR 4.7 BILLION.COMPARABLE ORDER INTAKE GROWTH IN Q3 IS EXPECTED TO BE FLAT ON BACK OF STRONG 11% GROWTH IN Q3 OF 2018.GROUP ADJUSTED EBITA FOR Q3 IS EXPECTED TO BE AROUND EUR 583 MILLION, OR 12.4% OF SALES, COMPARED TO 13.2% IN Q3 2018.Q3 NET INCOME FROM CONTINUING OPERATIONS IS EXPECTED TO AMOUNT TO APPROXIMATELY EUR 210 MILLION IN QUARTER.WE EXPECT THAT FULL YEAR 2019 ADJUSTED EBITA MARGIN IMPROVEMENT FOR GROUP WILL BE 10 TO 20 BASIS POINTS.FOR 2020, WE EXPECT TO DELIVER A 4-6% COMPARABLE SALES GROWTH AND AN ADJUSTED EBITA MARGIN IMPROVEMENT OF AROUND 100 BASIS POINTS.

Philips Signs Agreement To Create Digitalized Pathology Department In Taiwan

Aug 22 (Reuters) - Koninklijke Philips NV <PHG.AS>::PHILIPS SIGNS AGREEMENT TO CREATE TAIWAN’S FIRST FULLY DIGITALIZED PATHOLOGY DEPARTMENT.

Siemens Healthineers: We Don't Expect Philips To Intervene In Planned Acquisition Of Corindus

Aug 8 (Reuters) - Siemens Healthineers <SHLG.DE>::SAYS WE DON'T EXPECT PHILIPS <<<PHG.AS>>> TO INTERVENE IN OUR PLANNED ACQUISITION OF CORINDUS <<<CVRS.A>>>.

Philips Q2 Adjusted EBITA Beats Company-Compiled Poll

July 22 (Reuters) - Koninklijke Philips NV <PHG.AS>::PHILIPS DELIVERS Q2 SALES OF EUR 4.7 BILLION, WITH 6% COMPARABLE SALES GROWTH AND 8% COMPARABLE ORDER INTAKE GROWTH; INCOME FROM CONTINUING OPERATIONS INCREASES TO EUR 260 MILLION AND ADJUSTED EBITA MARGIN IMPROVES TO 11.8%.WE CONTINUE TO EXPECT OUR PERFORMANCE MOMENTUM TO FURTHER IMPROVE IN SECOND HALF OF YEAR.SALES IN QUARTER AMOUNTED TO EUR 4.7 BILLION, WITH 6% COMPARABLE SALES GROWTH.Q2 OPERATING CASH FLOW AMOUNTED TO EUR 390 MILLION, COMPARED TO EUR 130 MILLION IN Q2 2018; FREE CASH FLOW WAS EUR 174 MILLION.Q2 COMPARABLE ORDER INTAKE INCREASED 8%.WE MAINTAIN OUR OVERALL TARGETS FOR 2017-2020 PERIOD..Q2 INCOME FROM CONTINUING OPERATIONS INCREASED TO EUR 260 MILLION, COMPARED TO EUR 186 MILLION IN Q2 2018.Q2 EPS INCREASED AS INCOME FROM CONTINUING OPERATIONS PER SHARE (DILUTED) AMOUNTED TO EUR 0.28;.Q2 ADJUSTED EBITA MARGIN WAS 11.8% OF SALES, COMPARED TO 11.2% OF SALES IN Q2 2018.Q2 ADJUSTED EPS INCREASED 23% AS ADJUSTED INCOME FROM CONTINUING OPERATIONS PER SHARE (DILUTED) AMOUNTED TO EUR 0.43.Q2 INCOME FROM OPERATIONS INCREASED TO EUR 350 MILLION, COMPARED TO EUR 298 MILLION IN Q2 2018.Q2 ATTRIBUTABLE NET INCOME EUR 256 MILLION VERSUS EUR 239 MILLION IN COMPANY-COMPILED CONSENSUS.ADJUSTED EBITA MARGIN FOR GROUP IMPROVED BY 60 BASIS POINTS, MAINLY DRIVEN BY PERFORMANCE IMPROVEMENT OF DIAGNOSIS & TREATMENT BUSINESSES - CEO.Q2 ADJUSTED EBITA EUR 549 MLN VS EUR 542 MLN IN COMPANY-COMPILED CONSENSUS.

Royal Philips Acquires Boston-Based Start-Up Company Medumo

July 18 (Reuters) - Royal Philips::ROYAL PHILIPS - HAS EXPANDED ITS PATIENT MANAGEMENT SOLUTIONS IN U.S. WITH ACQUISITION OF BOSTON-BASED START-UP COMPANY MEDUMO.

Philips, Catholic University Of Korea Team Up To Improve Cancer Diagnosis

July 11 (Reuters) - Koninklijke Philips NV <PHG.AS>::CATHOLIC UNIVERSITY OF KOREA SEOUL ST. MARY'S HOSPITAL AND PHILIPS TEAM UP TO IMPROVE CANCER DIAGNOSIS.

Philips Receives PMA Approval For Sale Of 'Heartstart' Defibrillators In US

June 27 (Reuters) - Koninklijke Philips NV <PHG.AS>::PHILIPS RECEIVES PRE MARKET APPROVAL (PMA) FROM FDA FOR SALE OF 'HEARTSTART' DEFIBRILLATORS IN THE US.

金融情報はリフィニティブから。すべての情報は少なくとも15分遅れで表示されています。

for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up